Amedeo's Top 20

Amedeo Smart

Independent Medical Education

22 January 2024

Multidisciplinary Journal Club

  1. Kim DeLuca E, Gebremariam A, Rose A, Biggerstaff M, et al.
    Cost-effectiveness of routine annual influenza vaccination by age and risk status.
    Vaccine 2023.

  1. Ensrud KE, Crandall CJ.
    Osteoporosis.
    Ann Intern Med 2024.

  2. Drysdale SB, Cathie K, Flamein F, Knuf M, et al.
    Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
    N Engl J Med 2023;389:2425-2435.

  3. Irving-Pease EK, Refoyo-Martinez A, Barrie W, Ingason A, et al.
    The selection landscape and genetic legacy of ancient Eurasians.
    Nature 2024;625:312-320.

  4. Cholerton B, Latimer CS, Crane PK, Corrada MM, et al.
    Neuropathologic Burden and Dementia in Nonagenarians and Centenarians.
    Neurology 2024;102:e208060.

  1. Bauer DC, Black DM, Dell R, Fan B, et al.
    Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case Cohort Study with Blinded Radiographic Review.
    J Clin Endocrinol Metab 2024.

  2. Vance JM, Farrer LA, Huang Y, Cruchaga C, et al.
    Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease.
    Ann Neurol 2024.

  3. Ku JH, Fischer H, Qian LX, Li K, et al.
    Latent tuberculosis infection testing practices in a large U.S. integrated healthcare system.
    Clin Infect Dis 2024.

  4. Stinchcombe TE, Wang X, Damman B, Mentlick J, et al.
    Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.
    J Clin Oncol 2024.

  5. O Briain E, Byrne AO, Dowling J, Kiernan J, et al.
    Diuretics use in the management of bronchopulmonary dysplasia in preterm infants: A systematic review.
    Acta Paediatr 2024.

  1. van Welzen BJ, Van Lelyveld SFL, Ter Beest G, Gisolf JH, et al.
    Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis.
    Clin Infect Dis 2024.

  2. Cerchietti L.
    Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B cell lymphoma.
    Blood 2024.

  3. Van Not OJ, van den Eertwegh AJM, Haanen JB, van Rijn RS, et al.
    BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
    Cancer 2024.

  4. Jonas KG, Cannon TD, Docherty AR, Dwyer D, et al.
    Psychosis superspectrum I: Nosology, etiology, and lifespan development.
    Mol Psychiatry 2024.

  5. Framke E, Thygesen LC, Malmborg M, Schou M, et al.
    Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in Denmark.
    Mult Scler 2024.

  1. Rastogi P, O'Shaughnessy J, Martin M, Boyle F, et al.
    Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including
    J Clin Oncol 2024.

  2. Mian BM, Feustel PJ, Aziz A, Kaufman RP Jr, et al.
    Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial.
    J Urol 2024;211:205-213.

  3. Tosin MH, Goetz CG, Stebbins GT.
    Patient With Parkinson Disease and Care Partner Perceptions of Key Domains Affecting Health-Related Quality of Life.
    Neurology 2024;102:e208028.

  4. Hundemer GL, Agharazii M, Madore F, Vaidya A, et al.
    Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Circulation 2023.

  5. Florescu AM, Lannov LV, Younis S, Cullum CK, et al.
    No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study.
    Cephalalgia 2024;44:333102423122291.


more..

Privacy Policy